stockrowCytokinetics, Incorporated
CYTK Healthcare Biotechnology
Cytokinetics, Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $88.0 million, up 376.6% from fiscal 2024.
- Revenue
- +2,356.5%
- EPS
- +46.3%
- Free cash flow
- −6.73%
- Total debt
- −83.9%
Quarter to September 2026, against a year earlier
Follow CYTK
Alert me
Cytokinetics, Incorporated (CYTK) Operating margin
Cytokinetics, Incorporated's operating margin over the twelve months to 30 September 2026 was −625.2%, up 70.3 percentage points from fiscal 2025 (−695.4%). Over the past ten years it has ranged from −6,589.7% (fiscal 2023) to 17.6% (fiscal 2016); the current reading is higher than 36% of that period. That is below the Biotechnology industry median of 0.00% and below the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | −695.4% | 2,207.28 |
| FY2024 | −2,902.7% | 3,686.99 |
| FY2023 | −6,589.7% | (6,246.96) |
| FY2022 | −342.8% | (78.21) |
| FY2021 | −264.5% | (96.27) |
| FY2020 | −168.3% | 199.70 |
| FY2019 | −368.0% | (85.71) |
| FY2018 | −282.3% | 566.00 |
| FY2017 | −848.3% | (865.82) |
| FY2016 | 17.6% | 148.09 |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Sep 2026 | −351.3% | 274.61 |
| Jun 2026 | −626.0% | 322.74 |
| Mar 2026 | −948.7% | 55.91 |
| Dec 2025 | −1,004.6% | 7,608.78 |
| 43 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| KRYS Krystal Biotech, Inc. compare | 48.4% |
| PTGX Protagonist Therapeutics, Inc. compare | 20.7% |
| CAI Caris Life Sciences,�Inc. compare | 13.4% |
| CORT Corcept Therapeutics Incorporated compare | 11.5% |
| SYRE Spyre Therapeutics, Inc. compare | 0.00% |
| MDGL Madrigal Pharmaceuticals, Inc. compare | −10.7% |
| TWST Twist Bioscience Corporation compare | −33.6% |
| ARWR Arrowhead Pharmaceuticals, Inc. compare | −33.8% |
| CYTK Cytokinetics, Incorporated | −625.2% |
| Biotechnology industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on CYTK
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement